Member Info for Brondby

Couple of 300k tranches bought towards the end of the day there.

Ciz shares in conduit still worth £1 million even at $3 per share. Plus the loan facility is available if required.

Yes, this is what i meant.

AS is clearly delighted with them:

https://twitter.com/bullish7777/status/1708757266189476092?t=x3sjUGxWCEc3PQtHI2m3_w&s=19

By pilot study I mean the clinical trials...

So, do we think some folks in the USA trading $CDT think they are trading CheckDot crypto currency (also CDT)? :-)

Like some others on here, for me CDT is a sideshow. If we sold all our shares now for 500k , nobody will care after the test is commercialised and ciz is sitting at an sp x10 todays.

The more I consider the BioTechne hook up, the more excited I get. That really enables global scalability and also means a multi-billion dollar company is fully aware of just how well the test works. We could easily wake up one day to an offer before the pilot study is even formally announced.

We can't say when news is going to drop, but its hard to see it not dropping eventually!

Hence an easy hold.

The 8 day weighted moving average has crossed both the 200 day and 100 day moving averages during September and has moved in fast on the 50 day (sitting almost on top). Nice bull flags.

Positive turnaround from the long downtrend over the last 7 months.

It can be hard sitting on shares you feel will be worth a fortune one day when the market shoes no patience, so nice to finally be in an uptrend.

I will be pleasantly surprised by earlier commercialisation. Regardless, I don’t think the SP will stay this low for long with the coming newsflow.

OBD has shown just how valuable such a test can be.

Prostate and lung cancer have similar incidence in the UK and USA, but in China (where Allan is now) lung cancer is the most prevalent cancer.

Its neither a simple or silly way of looking at it, and companies are always very reluctant to put timescales on anything, as the market punishes severely any missed deadlines!

If you watch the stockboz interview here it gives an indication of what is still to be done:

https://youtu.be/fUaOFpVwERM?si=in74P1CLuKnchl6r

And in one of the interviews back in March 2023, AS indicated around 6 months from the point they have everything ready to go (platform, re-agents etc.) to commercialisation.

So my guess would be anything between 6 and 9 months. However ciz has a habit of surprising us (e.g. recent BioTechne platform trial completion, which we didnt know was already initiated). And I strongly suspect the share price will not stay this low for the duration of that period as more news emerges.

My approach hers is one of an investor with a multi-year timeframe. I'd rather be in with a large (for me) stake now, than chase it when its double the price.

I think they were actually genuine sells. No obvious shenanigans from the MMs here with the bid at 2.30 throughout.

Sometimes value is just staring you in the face and some folks just dont see it!

A look at OBD again today shows what awaits CIZ on commercialisation of the test. OBD MC now up to 90 million. CIZ 9 million.

Hiding in plain sight.

I'm pleased its rising slowly and consolidating. Means traders get bored and disappear.

I'm here for the 40p to £1 levels so happy for it to stay lower for longer, at least until next pay day. I have buys from 1.6p into the 4s, so while its at these levels I'll add more.

Life changing gains possible here from this low mc, if you have a decent position.

Not getting mine until at least 10p

Lots of rounded small buys. Trying to keep the price down, but its not working. Small amounts move this share quickly.

Should hopefully clear out a few more 10%ers.

Possibly spurred on by Charles Archer...

https://investingstrategy.co.uk/biotech/cizzle-shares-breaking-down-interim-results/

Yes, Biotechne could potentially buy Ciz out.

They would certainly be well aware of the potential here. Our mc is currently tiny. But i would expect even an early buyout would need to be in the 30-40p range. Our major shareholders also know what the value of this could be, and the IPO was at 10p and they'd be looking for a multi-bagger return for carrying the risk.

Hence why I will just keep building as large a position as I can afford. We wont be at this level for much longer.

With many shares in sticky hands, this will be very hard to buy into in any size once a commercial test is announced.

Murf/conduit is a sideshow, latched onto by some traders after 10%. Many of them have dropped ciz already, but the churrn will help build a base of shareholders here for the bigger prize.

Exactly. Commercialisation of the test is where the big money will be made.

Look at #obd today. Their prostste cancer test has just seen their sp double, and market cap hit 40million (and it'll rise from there too)

Ciz's has low overheads, funds available, and now appears to be on the home run in after years of development work.

This is why I have spent over a year building a position.

Jace86. I agree, 40p doesn't reflect full potential over time. This share has potential to deliver life changing returns. But I didn't want to be accused of ramping!! 🤣

In reality, these things don't happen ovenight. But this share was 4.5p 6 months ago, and we're now further progressed to commercialisation and better funded.

But first we need to clear the 10% traders from this MURF/CDT merger to a move back to those levels.

Its likely we'll see another RNS soon, perhaps tomorrow, indicating what has been done regarding the PUT.

Remember MURF/CDT is a bit of a sideshow.

Main win is that we have liquid asset to fund the test development, which is where the big value lies.

Commercialise the test, and share price is many multiples from here. Buy out would potentially be on the cards.

The IPO was 10p. Those investing would have been looking for multiples from there for shouldering the risk.

40p is not unreasonable in a year or so, in my opinion, if all goes well (and there are many years of work behind this already)

Only that I expect the SP will be multiples higher by then and I will regret not buying more at lower levels.

I think its entirely possible we will have a commercial test by then, or be very close to it. AS in Stockbox interview from March estimated around 6 months from SOP and reagents completion to a commercial lab developed test being available.